Article Versions Notes

Tsai C-Y, Chi H-C, Wu R-C, Weng C-H, Tai T-S, Lin C-Y, Chen T-D, Wang Y-H, Chou L-F, Hsu S-H, et al. Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma. Biomedicines. 2022; 10(1):8. https://doi.org/10.3390/biomedicines10010008

Tsai, Chung-Ying, Hsiang-Cheng Chi, Ren-Chin Wu, Cheng-Hao Weng, Tzong-Shyuan Tai, Chan-Yu Lin, Tai-Di Chen, Ya-Hui Wang, Li-Fang Chou, Shen-Hsing Hsu, and et al. 2022. "Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma" Biomedicines 10, no. 1: 8. https://doi.org/10.3390/biomedicines10010008

Tsai, C.-Y., Chi, H.-C., Wu, R.-C., Weng, C.-H., Tai, T.-S., Lin, C.-Y., Chen, T.-D., Wang, Y.-H., Chou, L.-F., Hsu, S.-H., Lin, P.-H., Pang, S.-T., & Yang, H.-Y. (2022). Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma. Biomedicines, 10(1), 8. https://doi.org/10.3390/biomedicines10010008